Amphastar Pharmaceuticals Inc (AMPH)
48.02
+0.14
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
47.98
-0.04
(-0.08%)
After-Hours: 20:00
Amphastar Pharmaceuticals Free Cash Flow: 178.13M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 178.13M |
| March 31, 2024 | 160.93M |
| December 31, 2023 | 145.34M |
| September 30, 2023 | 139.83M |
| June 30, 2023 | 100.44M |
| March 31, 2023 | 51.43M |
| December 31, 2022 | 65.15M |
| September 30, 2022 | 89.79M |
| June 30, 2022 | 70.39M |
| March 31, 2022 | 99.96M |
| December 31, 2021 | 70.54M |
| September 30, 2021 | 44.54M |
| June 30, 2021 | 52.36M |
| March 31, 2021 | 45.15M |
| December 31, 2020 | 23.41M |
| September 30, 2020 | 13.09M |
| June 30, 2020 | -10.77M |
| March 31, 2020 | 12.18M |
| December 31, 2019 | 0.207M |
| September 30, 2019 | 2.90M |
| June 30, 2019 | 26.73M |
| March 31, 2019 | -23.14M |
| Date | Value |
|---|---|
| December 31, 2018 | -8.617M |
| September 30, 2018 | -8.905M |
| June 30, 2018 | -20.99M |
| March 31, 2018 | -15.00M |
| December 31, 2017 | 4.11M |
| September 30, 2017 | 13.13M |
| June 30, 2017 | 16.67M |
| March 31, 2017 | 22.32M |
| December 31, 2016 | 17.18M |
| September 30, 2016 | 7.727M |
| June 30, 2016 | 12.37M |
| March 31, 2016 | 7.506M |
| December 31, 2015 | -5.315M |
| September 30, 2015 | -1.036M |
| June 30, 2015 | 9.134M |
| March 31, 2015 | 7.777M |
| December 31, 2014 | 0.553M |
| September 30, 2014 | 1.712M |
| June 30, 2014 | -11.53M |
| March 31, 2014 | 7.611M |
| December 31, 2013 | 12.74M |
Free Cash Flow Range, Past 5 Years
-10.77M
Minimum
Jun 2020
178.13M
Maximum
Jun 2024
67.75M
Average
58.76M
Median
Free Cash Flow Benchmarks
| Omeros Corp | -155.53M |
| Harrow Inc | -20.74M |
| PetIQ Inc | 11.98M |
| Amneal Pharmaceuticals Inc | 176.08M |
| Alector Inc | -217.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 69.11M |
| Cash from Investing (Quarterly) | -69.90M |
| Cash from Financing (Quarterly) | -10.72M |
| Free Cash Flow Per Share (Quarterly) | 1.212 |
| Free Cash Flow to Equity (Quarterly) | 70.40M |
| Free Cash Flow to Firm (Quarterly) | 67.05M |
| Free Cash Flow Yield | 7.00% |